INNOVATIONS in Pharmacy (Nov 2021)

Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report

  • Michael J. Schuh,
  • Sheena Crosby

DOI
https://doi.org/10.24926/iip.v12i4.4034
Journal volume & issue
Vol. 12, no. 4

Abstract

Read online

Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.

Keywords